Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BCL2L1 Antikörper (Biotin)

Der Maus Monoklonal Anti-BCL2L1-Antikörper wurde für FACS validiert. Er ist geeignet, BCL2L1 in Proben von Human zu detektieren. Es ist 1 Publikation verfügbar.
Produktnummer ABIN135023

Kurzübersicht für BCL2L1 Antikörper (Biotin) (ABIN135023)

Target

Alle BCL2L1 Antikörper anzeigen
BCL2L1 (BCL2-Like 1 (BCL2L1))

Reaktivität

  • 236
  • 136
  • 120
  • 51
  • 25
  • 12
  • 10
  • 10
  • 5
  • 5
  • 4
  • 2
  • 2
  • 1
Human

Wirt

  • 170
  • 95
  • 1
Maus

Klonalität

  • 152
  • 114
Monoklonal

Konjugat

  • 139
  • 26
  • 11
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser BCL2L1 Antikörper ist konjugiert mit Biotin

Applikation

  • 181
  • 100
  • 64
  • 61
  • 57
  • 44
  • 32
  • 28
  • 28
  • 27
  • 21
  • 14
  • 10
  • 7
  • 6
  • 4
  • 3
  • 3
  • 2
  • 2
Flow Cytometry (FACS)

Klon

7B2-5
  • Spezifität

    Human/Mouse/Rat/Rhesus Bcl-xL

    Produktmerkmale

    Mouse Anti-Bcl-xL-BIOT

    Immunogen

    Recombinant human Bcl-xS

    Isotyp

    IgG3
  • Applikationshinweise

    • Applications: FC - Quality tested , IHC-PS - Reported in literature , ICC - Reported in literature , WB - Reported in literature , IP - Reported in literature , ELISA - Reported in literature
    • Working Dilutions: Flow Cytometry FITC and BIOT conjugates 3 g/106 cells PE conjugate 0.3 g/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L Immunoblotting Purified (UNLB) antibody 1 g/mL

    Probenmenge

    1 mL

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    0.1 mg/mL

    Buffer

    0.1 mg in 1.0 mL PBS/Sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Protect conjugated products from light.
    Each reagent is stable for the period shown on the bottle label if stored as directed.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Store at 2-8°C
  • Gottschalk, Boise, Oltvai, Accavitti, Korsmeyer, Quintáns, Thompson: "The ability of Bcl-x(L) and Bcl-2 to prevent apoptosis can be differentially regulated." in: Cell death and differentiation, Vol. 3, Issue 1, pp. 113-8, (2006) (PubMed).

  • Target

    BCL2L1 (BCL2-Like 1 (BCL2L1))

    Andere Bezeichnung

    Bcl-xL

    Hintergrund

    Apoptosis, or programmed cell death, is a well-documented phenomenon in many cellular systems. It plays a key role in tissue and organ development as well as in adult tissues during cell turnover. Apoptosis can be induced by a variety of internal and external stimuli including growth factor deprivation, cytokine treatment, antigen-receptor engagement, cell-cell interactions, irradiation and glucocorticoid treatment. Bcl-2 and one of its homologues, Bcl-xL, protect cells from apoptosis, while other homologues of Bcl-2 such as Bax, Bad and Bak have been shown to enhance apoptosis. Bcl-xL has been shown to block apoptosis which is induced by a variety of stimuli and, under certain conditions, offers greater protection against apoptosis than Bcl-2. In contrast, Bad and Bax inhibit the protective functions of Bcl-xL and Bcl-2, respectively. Although heterodimerization between Bcl-xL/Bad and Bcl-2/Bax was originally thought to be essential for the differential anti-apoptotic activity of Bcl-xL and Bcl-2, other results suggest that the formation of heterodimers may not be necessary for this death-repressing activity.

    Pathways

    Apoptose, Negative Regulation of intrinsic apoptotic Signaling
Sie sind hier:
Chat with us!